Read + Share
Amedeo Smart
Independent Medical Education
Bringeland GH, Blaser N, Myhr KM, Vedeler CA, et al. Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic. J Neurol Sci 2021;429:117622.PMID: 34474301
Email
LinkedIn
Facebook
Twitter
Privacy Policy